文献速递胸部肿瘤乳腺癌支持与姑息治疗

1990至2050年17种癌症全球总发病与诊断发病及分期分布的模拟分析

Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers.
PubMed 文献 · Lancet Oncol · 2026-01-01

该研究构建全球癌症人力微模拟模型,模拟200个国家地区17种癌症1990至2050年发病与分期。

核心结论

  • 全球17种癌症负担巨大且增长,中低收入国家尤为突出,许多患者未诊断即死亡。

研究设计与样本

  • 研究构建全球癌症人力微模拟模型,模拟200个国家地区17种癌症1990至2050年发病与分期。
  • 模型考虑人口趋势和卫生系统因素,包括10类癌症诊断相关人力人员,并校准至诊断癌症发病与分期经验数据。

主要发现

  • 肺癌、乳腺癌和前列腺癌预计仍为全球最常诊断癌症。

临床怎么用

  • 模型框架可评估针对性干预以加强癌症人力并改善诊断路径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer incidence is increasing globally, with the largest burden in low-income and middle-income countries. Workforce shortages and health system barriers contribute to substantial diagnostic delays and underdiagnosis, but estimates of undiagnosed cancer burden are lacking. The aim of this study was to estimate incidence (total and diagnosed) and stage at diagnosis in each country for 17 cancers from 1990 to 2050. METHODS: We developed the Global Cancer Workforce microsimulation model to simulate 17 cancer types (oral, nasopharynx, oesophagus, stomach, colon, rectum, anus, liver, pancreas, lung, skin melanoma, breast, cervix uteri, ovary, prostate, bladder, and brain and CNS) in 200 countries and territories from 1990 to 2050, accounting for demographic trends and health system factors, including ten specific workforce personnel types relevant to cancer diagnosis. We calibrated the incidence module to empirical data on diagnosed cancer incidence and stage distribution at diagnosis. Using the calibrated model, we estimated both total (underlying) and diagnosed crude and age-standardised incidence rates (per 100 000 population) and numbers of cancer cases for each country and region from 1990 to 2050. We also estimated the proportion of cancers diagnosed at each stage (I-IV). FINDINGS: Globally, among the 17 cancers included in the model, diagnosed cancer incidence was projected to increase from 13·58 million (95% uncertainty interval [UI] 12·17-14·51) cases in 2025 to 19·32 million (17·65-21·33) in 2050. Lung, breast, and prostate cancers were projected to remain the most commonly diagnosed cancers globally. The proportions of incident cancers that die undiagnosed showed large disparities by region, ranging from 0·9% (95% UI 0·6-1·3) in western Europe to 67·4% (60·1-74·2) in western Africa, with a global average of 31·5% (28·1-36·7). Globally, the proportion of cancers diagnosed at advanced stages (III-IV) was projected to decline slightly, from 45·7% (44·7-46·7) in 2025 to 44·7% (43·7-45·7) in 2050, with worse stage distributions in Africa and Asia compared with other regions. INTERPRETATION: These findings highlight the substantial and growing burden of cancers, especially in low-income and middle-income countries, where many people who develop cancer die undiagnosed. Accounting for demographic and epidemiological trends as well as health system factors, our modelling framework enables evaluation of targeted interventions to strengthen the cancer workforce and improve diagnostic pathways across diverse geographical and socioeconomic settings. FUNDING: American Cancer Society and Breast Cancer Research Foundation.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Ward ZJ, Moraes FY, Scott AM, et al. Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers. Lancet Oncol. 2026. PMID: 42061367. doi:10.1016/S1470-2045(26)00060-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。